Rohit Joshi

Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer

Thierry André, Elena Élez, Eric Van Cutsem et al. · New England Journal of Medicine · 2024 · 213 citations

Medicine, Oncology, Pharmacotherapy +17

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

Thierry André, Elena Élez, Heinz‐Josef Lenz et al. · The Lancet · 2025 · 179 citations

Medicine, Oncology, Immunotherapy +12

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease

Magnus Ekström, Diana Ferreira, Sungwon Chang et al. · JAMA · 2022 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study

Kerri Beckmann, Alice Bennett, Graeme P. Young et al. · BMC Health Services Research · 2015 · 59 citations · Full text

Medicine, Demography, Oncology +17